ArticleInternational journal of pharmaceutics: X2022

Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal.

Sahar Eljack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.